text: Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.
option_0: Heparin-induced thrombocytopenia primary prevention
option_1: Heparin-induced thrombocytopenia future or investigational therapies
option_2: Glanzmann's thrombasthenia medical therapy
option_3: Heparin-induced thrombocytopenia medical therapy
option_4: Thrombotic thrombocytopenic purpura secondary prevention
option_5: Antiphospholipid syndrome primary prevention
option_6: Antiphospholipid syndrome secondary prevention
option_7: Glanzmann's thrombasthenia future or investigational therapies